Retreatment criteria |
 BCVA decrease by 0.10 from BCVA gained at 12-week review or last visit |
 OCT CMT increase by 75 µm from CMT attained at 12-week review |
 The appearance of new IRF spaces in central 1.5 mm, i.e. 750 µm from the foveal centre |
 The appearance of new SRF space in central 1.5 mm, i.e. 750 µm from the foveal centre |
 Increase in SRF height from the status achieved at 12-week review |